Evidence for a quantitative trait locus for plasma fibrinogen from a family–based association study

Studies in unrelated individuals have shown an association between fibrinogen gene polymorphisms and plasma fibrinogen levels, which is itself a risk factor for coronary heart disease. Family-based studies have complementary strengths in the investigation of such hypothesized genetic associations. Genotypes at the β-fibrinogen -455G/A promoter polymorphism, and a neighbouring highly polymorphic microsatellite in the α-fibrinogen gene were examined for evidence of genetic linkage and association with plasma fibrinogen in 568 members of 97 Caucasian families. The heritability of plasma fibrinogen was 0.22 ± 0.08, P = 0.0007. There was no significant evidence of genetic linkage between the fibrinogen locus and plasma fibrinogen with either marker. In contrast, there was evidence for association of plasma fibrinogen with genotype at the β-455G/A polymorphism (χ12 = 11.12; P = 0.0009). Tests examining allelic transmission from heterozygous parents confirmed this association (Monk’s test, T = 2.17; P = 0.03). Genotype at the β-455G/A polymorphism accounted for 2% of the observed variation in fibrinogen. This is equivalent to about 10% of the heritable component, suggesting the presence of other quantitative trait loci (QTL) in unlinked genes. Confirmation of the association of plasma fibrinogen with genotype at the β-455G/A polymorphism in families indicates that the association is due to the physical proximity of this marker to a QTL, although the effect of this QTL was too small to be detected by linkage in this study. These findings are of potential importance for the design of genetic studies of multifactorial quantitative traits.

[1]  N. Risch Searching for genetic determinants in the new millennium , 2000, Nature.

[2]  D. Levy,et al.  Association of blood pressure with fibrinolytic potential in the Framingham offspring population. , 2000, Circulation.

[3]  A. Hamsten,et al.  Two common, functional polymorphisms in the promoter region of the beta-fibrinogen gene contribute to regulation of plasma fibrinogen concentration. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[4]  G. Lathrop,et al.  Fine-mapping of an ancestral recombination breakpoint in DCP1 , 1999, Nature Genetics.

[5]  G. Fuller,et al.  Detection of a complex that associates with the Bbeta fibrinogen G-455-A polymorphism. , 1998, Blood.

[6]  J. Pankow,et al.  Segregation analysis of plasminogen activator inhibitor-1 and fibrinogen levels in the NHLBI family heart study. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[7]  M Farrall,et al.  Measured haplotype analysis of the angiotensin-I converting enzyme gene. , 1998, Human molecular genetics.

[8]  J R O'Connell,et al.  PedCheck: a program for identification of genotype incompatibilities in linkage analysis. , 1998, American journal of human genetics.

[9]  D. Altshuler,et al.  Genetic polymorphisms and disease. , 1998, The New England journal of medicine.

[10]  R Peto,et al.  Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. , 1998, JAMA.

[11]  L. Almasy,et al.  Multipoint quantitative-trait linkage analysis in general pedigrees. , 1998, American journal of human genetics.

[12]  R. De Cristofaro,et al.  Measurement of plasma fibrinogen concentration by the prothrombin-time-derived method: applicability and limitations , 1998, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[13]  J. Terwilliger,et al.  Genetic susceptibility for human familial essential hypertension in a region of homology with blood pressure linkage on rat chromosome 10. , 1997, Human molecular genetics.

[14]  S. Humphries,et al.  A common mutation (G-455--> A) in the beta-fibrinogen promoter is an independent predictor of plasma fibrinogen, but not of ischemic heart disease. A study of 9,127 individuals based on the Copenhagen City Heart Study. , 1997, Journal of Clinical Investigation.

[15]  N Risch,et al.  The Future of Genetic Studies of Complex Human Diseases , 1996, Science.

[16]  M. Blettner,et al.  Tel Aviv-Heidelberg three-generation offspring study: genetic determinants of plasma fibrinogen level. , 1996, American journal of medical genetics.

[17]  D. Arveiler,et al.  Beta fibrinogen gene polymorphisms are associated with plasma fibrinogen and coronary artery disease in patients with myocardial infarction. The ECTIM Study. Etude Cas-Temoins sur l'Infarctus du Myocarde. , 1996, Circulation.

[18]  J. O’Connell,et al.  The VITESSE algorithm for rapid exact multilocus linkage analysis via genotype set–recoding and fuzzy inheritance , 1995, Nature Genetics.

[19]  P. de Knijff,et al.  Gender-related association between beta-fibrinogen genotype and plasma fibrinogen levels and linkage disequilibrium at the fibrinogen locus in Greenland Inuit. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[20]  Y. Friedlander,et al.  Genetic and environmental sources of fibrinogen variability in Israeli families: the Kibbutzim Family Study. , 1995, American journal of human genetics.

[21]  G. Assmann,et al.  Impact of polymorphisms in the alpha- and beta-fibrinogen gene on plasma fibrinogen concentrations of coronary heart disease patients. , 1995, Thrombosis research.

[22]  D. Beevers,et al.  Abnormalities of rheology and coagulation in hypertension. , 1994, Journal of human hypertension.

[23]  L. Berkman,et al.  Genetic susceptibility to death from coronary heart disease in a study of twins. , 1994, The New England journal of medicine.

[24]  T. Reed,et al.  Minimal genetic influences on plasma fibrinogen level in adult males in the NHLBI twin study , 1994, Clinical genetics.

[25]  M. Blombäck,et al.  The Role of β-Fibrinogen Genotype in Determining Plasma Fibrinogen Levels in Young Survivors of Myocardial Infarction and Healthy Controls from Sweden , 1993, Thrombosis and Haemostasis.

[26]  N Risch,et al.  The A1 allele at the D2 dopamine receptor gene and alcoholism. A reappraisal. , 1993, JAMA.

[27]  J. Murray,et al.  Tetranucleotide repeat polymorphism at the human alpha fibrinogen locus (FGA). , 1992, Human molecular genetics.

[28]  P. Donnan,et al.  Genetic variation at fibrinogen loci and plasma fibrinogen levels. , 1992, Journal of medical genetics.

[29]  H. Tunstall-Pedoe,et al.  Rheological determinants of blood pressure in a Scottish adult population , 1992, Journal of hypertension.

[30]  S. Humphries,et al.  Variation in the Promoter Region of the β Fibrinogen Gene Is Associated with Plasma Fibrinogen Levels in Smokers and Non-Smokers , 1991, Thrombosis and Haemostasis.

[31]  P. Kierulf,et al.  DNA polymorphisms at fibrinogen loci and plasma fibrinogen concentration , 1989, Clinical genetics.

[32]  R. Williams,et al.  Gm3;5,13,14 and type 2 diabetes mellitus: an association in American Indians with genetic admixture. , 1988, American journal of human genetics.

[33]  M. Blombäck,et al.  GENETIC AND CULTURAL INHERITANCE OF PLASMA FIBRINOGEN CONCENTRATION , 1987, The Lancet.

[34]  S. Yu,et al.  Intracellular assembly of human fibrinogen. , 1983, The Journal of biological chemistry.

[35]  G. Abecasis,et al.  A general test of association for quantitative traits in nuclear families. , 2000, American journal of human genetics.

[36]  H. Clink,et al.  Letter: Quality and quantity of survival in acute myeloid leukaemia. , 1975, Lancet.